These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9645341)

  • 41. Elevated serum LDH in patients with non-Hodgkin's lymphoma: not always an ominous sign.
    Steensma DP; Witzig TE
    Br J Haematol; 1999 Nov; 107(2):463-4. PubMed ID: 10583243
    [No Abstract]   [Full Text] [Related]  

  • 42. Serum level of intercellular adhesion molecule-1 in children with malignant lymphoma.
    Abdelrazik N; Fouda M; Zaghloul MH; Abbas D
    Med Princ Pract; 2008; 17(3):233-8. PubMed ID: 18408393
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Clinical significance of serum lactate dehydrogenase, β2-microglobulin and vascular endothelial growth factor level detection in patients with non-Hodgkin's lymphoma].
    Duan Y; Li G; Hu HX
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Jun; 20(3):608-10. PubMed ID: 22739165
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lymphocyte homing and clinical behavior of non-Hodgkin's lymphoma.
    Jalkanen S; Joensuu H; Söderström KO; Klemi P
    J Clin Invest; 1991 May; 87(5):1835-40. PubMed ID: 2022749
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical relevance of soluble HLA-I and beta2-microglobulin levels in non-Hodgkin's lymphoma and Hodgkin's disease.
    Albitar M; Vose JM; Johnson MM; Do KA; Day A; Jilani I; Kantarjian H; Keating M; O'Brien SM; Verstovsek S; Armitage JO; Giles FJ
    Leuk Res; 2007 Feb; 31(2):139-45. PubMed ID: 16545870
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Presentation serum selenium predicts for overall survival, dose delivery, and first treatment response in aggressive non-Hodgkin's lymphoma.
    Last KW; Cornelius V; Delves T; Sieniawska C; Fitzgibbon J; Norton A; Amess J; Wilson A; Rohatiner AZ; Lister TA
    J Clin Oncol; 2003 Jun; 21(12):2335-41. PubMed ID: 12805335
    [TBL] [Abstract][Full Text] [Related]  

  • 47. High serum levels of soluble CD44 variant isoform v5 are associated with favourable clinical outcome in ovarian cancer.
    Zeimet AG; Widschwendter M; Uhl-Steidl M; Müller-Holzner E; Daxenbichler G; Marth C; Dapunt O
    Br J Cancer; 1997; 76(12):1646-51. PubMed ID: 9413956
    [TBL] [Abstract][Full Text] [Related]  

  • 48. High baseline serum thymidine kinase 1 level predicts unfavorable outcome in patients with follicular lymphoma.
    Procházka V; Faber E; Raida L; Langová K; Indrák K; Papajík T
    Leuk Lymphoma; 2012 Jul; 53(7):1306-10. PubMed ID: 22263569
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The role of alternative splicing of the adhesion molecule, CD44, in lymphoid malignancy.
    Irving JA; Cain G; Howard M; Angus B; Taylor PR; Cattan AR
    J Clin Pathol; 1998 Oct; 51(10):776-80. PubMed ID: 10023342
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Results of treatment with high intensity, brief duration chemotherapy in poor prognosis non-Hodgkin's lymphoma.
    McMaster ML; Greer JP; Wolff SN; Johnson DH; Greco FA; Stein RS; Cousar JB; Flexner JM; Hainsworth JD
    Cancer; 1991 Jul; 68(2):233-41. PubMed ID: 1712662
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Factors influencing the survival of children with Non-Hodgkin's disease].
    Kiselev AV
    Vestn Ross Akad Med Nauk; 1996; (10):26-8. PubMed ID: 8998428
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prognostic significance of elevated serum CD44 levels in patients with oral squamous cell carcinoma.
    Sawant S; Ahire C; Dongre H; Joshi S; Jamghare S; Rane P; Kane S; Chaukar D
    J Oral Pathol Med; 2018 Aug; 47(7):665-673. PubMed ID: 29752852
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Low serum levels of soluble CD44 variant 6 are significantly associated with poor prognosis in patients with pancreatic carcinoma.
    Gansauge F; Gansauge S; Rau B; Scheiblich A; Poch B; Schoenberg MH; Beger HG
    Cancer; 1997 Nov; 80(9):1733-9. PubMed ID: 9351541
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Blood serum levels of soluble forms of adhesion molecules ICAM-1 (sICAM-1) and selectin E (s-selectin E) in patients with various phases of non-Hodgkin's lymphomas.
    Wołowiec D; Frydecka I; Kapelko-Słowik K; Potoczek S; Urbaniak-Kujda D; Kuliczkowski K
    Med Sci Monit; 2002 May; 8(5):BR175-8. PubMed ID: 12011765
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Serum levels of interleukin-6 and interleukin-10 in Turkish patients with aggressive non-Hodgkin's lymphoma.
    Guney N; Soydinc HO; Basaran M; Bavbek S; Derin D; Camlica H; Yasasever V; Topuz E
    Asian Pac J Cancer Prev; 2009; 10(4):669-74. PubMed ID: 19827892
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prognostic significance of serum lactate dehydrogenase in malignant lymphoma.
    Schneider RJ; Seibert K; Passe S; Little C; Gee T; Lee BJ; Miké V; Young CW
    Cancer; 1980 Jul; 46(1):139-43. PubMed ID: 6992974
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Serum CA 125 as a prognostic factor in non-Hodgkin's lymphoma.
    Bairey O; Blickstein D; Stark P; Prokocimer M; Nativ HM; Kirgner I; Shaklai M
    Leuk Lymphoma; 2003 Oct; 44(10):1733-8. PubMed ID: 14692526
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Serum LDH concentration in non-Hodgkin's lymphomas. Relationship to histologic type, tumor mass, and presentation features.
    Fasola G; Fanin R; Gherlinzoni F; Galieni P; Taruscio D; Frezza G; Mazza P; Pileri S; Baccarani M
    Acta Haematol; 1984; 72(4):231-8. PubMed ID: 6438991
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Elevated levels of soluble CD44 precede the development of AIDS-associated non-Hodgkin's B-cell lymphoma.
    Breen EC; Epeldegui M; Boscardin WJ; Widney DP; Detels R; Martínez-Maza O
    AIDS; 2005 Oct; 19(15):1711-2. PubMed ID: 16184051
    [No Abstract]   [Full Text] [Related]  

  • 60. High serum interleukin-6 levels correlate with a shorter failure-free survival in indolent lymphoma.
    Fayad L; Cabanillas F; Talpaz M; McLaughlin P; Kurzrock R
    Leuk Lymphoma; 1998 Aug; 30(5-6):563-71. PubMed ID: 9711918
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.